Prognostic value of folate-associated gene expression in stage II colon cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2025, v. 151, n. 2, p. 1, doi. 10.1007/s00432-025-06141-w
- By:
- Publication type:
- Article
Works by Odin, Elisabeth
Results: 20
1
2
Pretherapeutic uracil and dihydrouracil levels of colorectal cancer patients are associated with sex and toxic side effects during adjuvant 5-fluorouracil-based chemotherapy.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 11, p. 2935, doi. 10.1002/cncr.26595
- By:
- Publication type:
- Article
3
Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 4, p. 619, doi. 10.1007/s00280-021-04318-x
- By:
- Publication type:
- Article
4
Plasma deoxyuridine as a surrogate marker for toxicity and early clinical response in patients with metastatic colorectal cancer after 5-FU-based therapy in combination with arfolitixorin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 1, p. 31, doi. 10.1007/s00280-020-04173-2
- By:
- Publication type:
- Article
5
Relationship between folate concentration and expression of folate-associated genes in tissue and plasma after intraoperative administration of leucovorin in patients with colorectal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
6
A pharmacokinetic and pharmacodynamic investigation of Modufolin® compared to Isovorin® after single dose intravenous administration to patients with colon cancer: a randomized study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
7
A pharmacokinetic and pharmacodynamic investigation of Modufolin compared to Isovorin after single dose intravenous administration to patients with colon cancer: a randomized study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 37, doi. 10.1007/s00280-014-2611-9
- By:
- Publication type:
- Article
8
Folate levels measured by LC-MS/MS in patients with colorectal cancer treated with different leucovorin dosages.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 6, p. 1167, doi. 10.1007/s00280-014-2591-9
- By:
- Publication type:
- Article
9
Pretherapeutic uracil and dihydrouracil levels in saliva of colorectal cancer patients are associated with toxicity during adjuvant 5-fluorouracil-based chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 757, doi. 10.1007/s00280-014-2553-2
- By:
- Publication type:
- Article
10
Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy-related genes.
- Published in:
- International Journal of Cancer, 2009, v. 124, n. 5, p. 1220, doi. 10.1002/ijc.23852
- By:
- Publication type:
- Article
11
Increasing Dosage of Leucovorin Results in Pharmacokinetic and Gene Expression Differences When Administered as Two-Hour Infusion or Bolus Injection to Patients with Colon Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 258, doi. 10.3390/cancers15010258
- By:
- Publication type:
- Article
12
Folate‐Associated Gene Expression in Primary Tumors Is Associated With Tumor Response and Progression‐Free Survival of Patients With Metastatic Colorectal Cancer Undergoing 5‐FU/Leucovorin‐Based Combination Chemotherapy.
- Published in:
- Cancer Medicine, 2025, v. 14, n. 9, p. 1, doi. 10.1002/cam4.70895
- By:
- Publication type:
- Article
13
Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1078, doi. 10.1007/s10637-015-0272-0
- By:
- Publication type:
- Article
14
Determination of reduced folates in tumor and adjacent mucosa of colorectal cancer patients using LC-MS/MS.
- Published in:
- Biomedical Chromatography, 2013, v. 27, n. 4, p. 487, doi. 10.1002/bmc.2816
- By:
- Publication type:
- Article
15
Expression of Folate Pathway Genes in Stage III Colorectal Cancer Correlates with Recurrence Status Following Adjuvant Bolus 5-FU-Based Chemotherapy.
- Published in:
- Molecular Medicine, 2015, v. 21, n. 1, p. 597, doi. 10.2119/molmed.2014.00192
- By:
- Publication type:
- Article
16
MTHFR, MTR, and MTRR Polymorphisms in Relation to p16INK4A Hypermethylation in Mucosa of Patients with Colorectal Cancer.
- Published in:
- Molecular Medicine, 2010, v. 16, n. 9/10, p. 425, doi. 10.2119/molmed.2009-00156
- By:
- Publication type:
- Article
17
p16INK4a Gene Promoter Hypermethylation in Mucosa as a Prognostic Factor for Patients with Colorectal Cancer.
- Published in:
- Molecular Medicine, 2008, v. 14, n. 7/8, p. 412, doi. 10.2119/2007-00096.Wettergren
- By:
- Publication type:
- Article
18
Folate Levels and Polymorphisms in the Genes MTHFR, MTR, and TS in Colorectal Cancer.
- Published in:
- Clinical Medicine Insights: Oncology, 2014, n. 8, p. 15, doi. 10.4137/CMO.S12701
- By:
- Publication type:
- Article
19
Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer.
- Published in:
- Clinical Medicine Insights: Oncology, 2012, n. 6, p. 347, doi. 10.4137/CMO.S10226
- By:
- Publication type:
- Article
20
Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer.
- Published in:
- Clinical Medicine Insights: Oncology, 2012, n. 6, p. 347, doi. 10.4137/CMO.S10226
- By:
- Publication type:
- Article